Not only is gene therapy under evaluation, but many pharmacological ways to upregulate utrophin are also being considered (see “The upregulation of utrophin by drug therapy is a plausible therapeutic approach in the treatment of DMD”). This evidence concerns the gene UTRN and Duchenne muscular dystrophy.